NAD+ in Australia: Research Guide, Forms & Where to Buy

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every living cell. It plays a central role in cellular energy production (as part of the mitochondrial electron transport chain), acts as a substrate for sirtuin proteins (which regulate gene expression and cellular stress responses), and is essential for the activity of PARP enzymes involved in DNA damage repair.

NAD+ levels decline with age, research suggests levels in human tissues may fall by 50% or more between ages 20 and 60. This decline has attracted significant scientific interest in NAD+ as a target for longevity and metabolic research.

NAD+ has been investigated across multiple research domains:

• Mitochondrial function and energy metabolism, NAD+ is essential for oxidative phosphorylation; research in rodent models has shown that NAD+ supplementation can partially restore mitochondrial function in aged tissue
• Sirtuin activation, sirtuins (particularly SIRT1 and SIRT3) require NAD+ as a co-substrate; research links sirtuin activity to metabolic regulation, inflammation modulation, and circadian rhythm control
• DNA repair, PARP1, a key DNA damage repair enzyme, consumes NAD+; research has examined the relationship between NAD+ levels, PARP activity, and genomic stability in ageing models
• Neurological research, NAD+ precursors have been investigated for neuroprotective effects in models of neurodegenerative conditions including Alzheimer's and Parkinson's disease
• Metabolic disorders, studies in mouse models of obesity have demonstrated that NAD+ precursor supplementation can improve insulin sensitivity and reduce adiposity

Human clinical trials of NAD+ precursors (notably NMN and NR) have shown that oral administration can raise blood NAD+ levels, though translation of the robust animal data to clinical outcomes in humans remains an active area of investigation.

Research into NAD+ biology uses several related compounds:

• NAD+, the coenzyme itself; used directly in in-vitro research; injectable NAD+ is studied for rapid cellular delivery bypassing oral bioavailability limitations
• NMN (nicotinamide mononucleotide), a direct NAD+ precursor; converted to NAD+ intracellularly via the salvage pathway; well-studied in both rodent and early human trials
• NR (nicotinamide riboside), another NAD+ precursor; first to demonstrate oral bioavailability in human trials; slightly different metabolic pathway than NMN

For in-vitro and injection-based research protocols, injectable NAD+ (typically supplied as a lyophilised powder for reconstitution) is the most direct option. OzPeps stocks NAD+ for research use, view current stock →

NAD+ sits at the intersection of several major longevity research pathways: mTOR signalling, AMPK activation, sirtuin activity, and mitochondrial biogenesis. Researchers studying hallmarks of ageing (including mitochondrial dysfunction, genomic instability, epigenetic alterations, and cellular senescence) frequently include NAD+ modulation as a variable.

David Sinclair's laboratory at Harvard (among others) has published extensively on NAD+ and sirtuin biology, and the compound has become a central focus of the longevity research field. Australian researchers are increasingly active in this space.

Research-grade NAD+ for laboratory use is available from Australian peptide suppliers. Key sourcing criteria:

• Lyophilised powder format for stability
• Local Australian stock for fast delivery

OzPeps supplies research-grade NAD+ with Australia-wide shipping. View NAD+ pricing and availability →

NAD+ products from OzPeps are sold strictly for laboratory and in-vitro research purposes. Not TGA-approved therapeutic goods. Not for human consumption. Researchers are responsible for all regulatory compliance.